Search research articles
Contact Us
Filters
Showing results (51-60 of 75) with videos related to
Page
of 8
Sort By:
European Urology Oncology
|
June 19, 2018
Docetaxel Treatment in PTEN- and ERG-aberrant Metastatic Prostate Cancers
Pasquale Rescigno, David Lorente, David Dolling, et al.
Neuro-Oncology Advances
|
May 31, 2021
Bintrafusp alfa (M7824), a bifunctional fusion protein targeting TGF-β and PD-L1: results from a phase I expansion cohort in patients with recurrent glioblastoma
Mustafa Khasraw, Michael Weller, David Lorente, et al.
European Urology
|
June 13, 2016
Decline in Circulating Tumor Cell Count and Treatment Outcome in Advanced Prostate Cancer
David Lorente, David Olmos, Joaquin Mateo, et al.
European Radiology
|
October 1, 2020
MGMT methylation may benefit overall survival in patients with moderately vascularized glioblastomas
Elies Fuster-Garcia, David Lorente Estellés, María Del Mar Álvarez-Torres, et al.
Clinical Genitourinary Cancer
|
June 2, 2016
Castration-Resistant Prostate Cancer Tissue Acquisition From Bone Metastases for Molecular Analyses
David Lorente, Aurelius Omlin, Zafeiris Zafeiriou, et al.
Plos One
|
December 29, 2017
Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma
Bert H O'Neil, John M Wallmark, David Lorente, et al.
European Urology
|
March 12, 2016
Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer
Pasquale Rescigno, David Lorente, Diletta Bianchini, et al.
Radiology
|
November 23, 2016
Diffusion-weighted Imaging as a Treatment Response Biomarker for Evaluating Bone Metastases in Prostate Cancer: A Pilot Study
Raquel Perez-Lopez, Joaquin Mateo, Helen Mossop, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 8, 2023
Darolutamide Maintenance in Patients With Metastatic Castration-Resistant Prostate Cancer With Nonprogressive Disease After Taxane Treatment (SAKK 08/16)
Silke Gillessen, Giuseppe Procopio, Stefanie Hayoz, et al.
European Urology
|
December 3, 2014
PTEN protein loss and clinical outcome from castration-resistant prostate cancer treated with abiraterone acetate
Roberta Ferraldeschi, Daniel Nava Rodrigues, Ruth Riisnaes, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 75) with videos related to
Sort By:
Page
of 8
European Urology Oncology
|
June 19, 2018
Docetaxel Treatment in PTEN- and ERG-aberrant Metastatic Prostate Cancers
Pasquale Rescigno, David Lorente, David Dolling, et al.
Neuro-Oncology Advances
|
May 31, 2021
Bintrafusp alfa (M7824), a bifunctional fusion protein targeting TGF-β and PD-L1: results from a phase I expansion cohort in patients with recurrent glioblastoma
Mustafa Khasraw, Michael Weller, David Lorente, et al.
European Urology
|
June 13, 2016
Decline in Circulating Tumor Cell Count and Treatment Outcome in Advanced Prostate Cancer
David Lorente, David Olmos, Joaquin Mateo, et al.
European Radiology
|
October 1, 2020
MGMT methylation may benefit overall survival in patients with moderately vascularized glioblastomas
Elies Fuster-Garcia, David Lorente Estellés, María Del Mar Álvarez-Torres, et al.
Clinical Genitourinary Cancer
|
June 2, 2016
Castration-Resistant Prostate Cancer Tissue Acquisition From Bone Metastases for Molecular Analyses
David Lorente, Aurelius Omlin, Zafeiris Zafeiriou, et al.
Plos One
|
December 29, 2017
Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma
Bert H O'Neil, John M Wallmark, David Lorente, et al.
European Urology
|
March 12, 2016
Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer
Pasquale Rescigno, David Lorente, Diletta Bianchini, et al.
Radiology
|
November 23, 2016
Diffusion-weighted Imaging as a Treatment Response Biomarker for Evaluating Bone Metastases in Prostate Cancer: A Pilot Study
Raquel Perez-Lopez, Joaquin Mateo, Helen Mossop, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 8, 2023
Darolutamide Maintenance in Patients With Metastatic Castration-Resistant Prostate Cancer With Nonprogressive Disease After Taxane Treatment (SAKK 08/16)
Silke Gillessen, Giuseppe Procopio, Stefanie Hayoz, et al.
European Urology
|
December 3, 2014
PTEN protein loss and clinical outcome from castration-resistant prostate cancer treated with abiraterone acetate
Roberta Ferraldeschi, Daniel Nava Rodrigues, Ruth Riisnaes, et al.
Page
of 8